What could be more valuable than a face mask that protects you from the SARS-CoV-2 virus? How about a face mask that offers protection and actually detects whether COVID-19 is present in your breath?

Biomedical engineers and nanomedical scientists have devised various ways in which nanoelectronic biosensors can address, diagnose, and monitor the progression of human diseases. Nanoelectronic ...

Biosensor technology can detect a biological event by the production of a measurable signal. The process of detection combines a recognition element for a type of biomolecule or chemical reaction with ...

The advent of precision medicine has significantly enhanced our understanding of individual patient responses to medical treatments. This approach considers unique genetic, physiological, and ...

High electron mobility transistors (HEMTs) have emerged as pivotal devices in the field of electronic sensing owing to their intrinsic ability to support a high-mobility two‐dimensional electron gas.

In a paper published in NANO, researchers from Hubei, China discuss the top-down and bottom-up strategies for the synthesis of Graphene quantum dots (GQDs). The respective advantages and disadvantages ...

The US Patent Office has recently published the patent application (no. US 2015/0301039), which was filed by the MIPT in May this year and is titled Biological Sensor and a Method of the Production of ...

Patient (pt) experience with a smartphone application (app) and biosensor for remote symptom monitoring during systemic cancer therapy: Qualitative findings from initial testing. This is an ASCO ...

Multiscale modeling intervention development and perspectives from early-stage breast cancer survivors on technology to improve long-term adherence to endocrine therapy. This is an ASCO Meeting ...

(Nanowerk News) The Moscow Institute of Physics and Technology (MIPT) is patenting biosensor chips based on graphene, graphene oxide and carbon nanotubes that will improve the analysis of biochemical ...

G-protein-coupled receptors (GPCRs) remain major drug targets, despite an incomplete understanding of how they signal through 16 non-visual G-protein signal transducers (collectively named the ...